SMT SAX Bulk Packings are silica-based Strong Anion eXchange packing developed for separation of anionic compounds. SMT SAX Bulk Packings consist of chemically attached hydrophilic surface derivatized to form quaternary amine.
SMT SAX Bulk Packings are silica-based Strong Anion eXchange packing developed for separation of anionic compounds. SMT SAX Bulk Packings consist of chemically attached hydrophilic surface derivatized to form quaternary amine.
SMT SAX Bulk Packings are silica-based Strong Anion eXchange packing developed for separation of anionic compounds. SMT SAX Bulk Packings consist of chemically attached hydrophilic surface derivatized to form quaternary amine.
SMT SAX Bulk Packings are silica-based Strong Anion eXchange packing developed for separation of anionic compounds. SMT SAX Bulk Packings consist of chemically attached hydrophilic surface derivatized to form quaternary amine.
SMT Phenyl bulk packings provides unique selectivity for aromatic compounds when compared to other reversed-phase packings such as C18 and C8. The ìÛ-electrons of the phenyl group can interact with the aromatic ring of an analyte to
SMT Phenyl bulk packings provides unique selectivity for aromatic compounds when compared to other reversed-phase packings such as C18 and C8. The ìÛ-electrons of the phenyl group can interact with the aromatic ring of an analyte to
An Hh signaling pathway inhibitor that acts by antagonizing SMO (IC<sub>50</sub>s = 1.3 and 2.5 nM for mouse and human, respectively) inhibits Gli1 mRNA expression and prevents tumor growth in a medulloblastoma allograft mouse model at 20 mg/kg/day.
An Hh signaling pathway inhibitor that acts by antagonizing SMO (IC<sub>50</sub>s = 1.3 and 2.5 nM for mouse and human, respectively) inhibits Gli1 mRNA expression and prevents tumor growth in a medulloblastoma allograft mouse model at 20 mg/kg/day.
An Hh signaling pathway inhibitor that acts by antagonizing SMO (IC<sub>50</sub>s = 1.3 and 2.5 nM for mouse and human, respectively) inhibits Gli1 mRNA expression and prevents tumor growth in a medulloblastoma allograft mouse model at 20 mg/kg/day.
An Hh signaling pathway inhibitor that acts by antagonizing SMO (IC<sub>50</sub>s = 1.3 and 2.5 nM for mouse and human, respectively) inhibits Gli1 mRNA expression and prevents tumor growth in a medulloblastoma allograft mouse model at 20 mg/kg/day.
Spherical shaped reaction vessel constructed with a flange having a groove formed in the sealing surface of the flange. Indentations increase agitation of the contents of the vessel during stirring.
Spherical shaped reaction vessel constructed with a flange having a groove formed in the sealing surface of the flange. Indentations increase agitation of the contents of the vessel during stirring.